Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: Multidrug-resistant (MDR) strains of represent an obstacle to eradicating tuberculosis (TB) due to the low treatment success rate of MDR TB. Among them, the MDR B0/W148 clone has recently evolved from the Beijing lineage 2 and is widely disseminated in Russia and Europe. To get more insights into the genetic factors underlying the evolutionary success of the MDR B0/W148 clone in addition to environmental and patient-related features, we focused on two mutations specific to this clone that are found in the transcriptional regulators WhiB6 and KdpDE and investigated in a H37Rv strain background the transcriptional profile associated with these mutations and their impact on the and growth characteristics. Through the construction and use of H37Rv∆, H37Rv∆, and complemented strains, neither mutation impaired the growth of in standard mycobacterial growth media. The mutation T51P in prevented the upregulation of 9 genes in the core region and 44 genes elsewhere in the genome, while the deletion of two nucleotides in leads to a fusion protein of KdpD with KdpE that inhibits the transcriptional activity of KdpE. Neither mutation led to hypervirulence in a mouse infection model. These results point to the role of other MDR B0/W148 specific mutations in the wide geographic diffusion of this clone and/or put in question a hypothesized hypervirulence as a driving factor for this large dissemination.

Importance: Human tuberculosis (TB), caused by the bacterium , remains a global public health issue estimated to have been responsible for 1.25 million deaths in 2023. Multidrug-resistant (MDR) strains of , resistant to rifampicin and isoniazid, lead to lower treatment success. Among them, the MDR B0/W148 clone has widely disseminated in Russia and Europe. To get more insights into the genetic factors underlying the evolutionary success of this clone, we investigated two strain-specific mutations found in the transcriptional regulators WhiB6 and KdpDE. By constructing and analyzing laboratory strains carrying these specific mutations, we found numerous changes in their transcriptional profiles, whereas we observed only a little impact of these mutations on the virulence of in a mouse infection model. Our study provides new insights into the transcriptional landscape of the selected MDR strains, although no direct connection to virulence could be established.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210973PMC
http://dx.doi.org/10.1128/spectrum.03224-24DOI Listing

Publication Analysis

Top Keywords

mdr b0/w148
16
mdr strains
12
b0/w148 clone
12
mdr
8
multidrug-resistant mdr
8
treatment success
8
disseminated russia
8
russia europe
8
europe insights
8
insights genetic
8

Similar Publications

Evaluation of the role of and in the dominant multidrug-resistant clone B0/W148.

Microbiol Spectr

July 2025

Cimi-Paris, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Paris, France.

Unlabelled: Multidrug-resistant (MDR) strains of represent an obstacle to eradicating tuberculosis (TB) due to the low treatment success rate of MDR TB. Among them, the MDR B0/W148 clone has recently evolved from the Beijing lineage 2 and is widely disseminated in Russia and Europe. To get more insights into the genetic factors underlying the evolutionary success of the MDR B0/W148 clone in addition to environmental and patient-related features, we focused on two mutations specific to this clone that are found in the transcriptional regulators WhiB6 and KdpDE and investigated in a H37Rv strain background the transcriptional profile associated with these mutations and their impact on the and growth characteristics.

View Article and Find Full Text PDF

Background: This study included tuberculosis (TB) patients from high-burden Russian regions of Siberia and Far East. We aimed to assess the impact of the COVID-19 pandemic on the genotypic structure of Mycobacterium tuberculosis population and on epidemiology and clinical course of tuberculosis in TB and TB/COVID-19 coinfected patients.

Methods: A total of 456 M.

View Article and Find Full Text PDF

Buryatia is a multidrug-resistant tuberculosis (MDR-TB) high-burden region in the Russian Far East with ethnically diverse population (30 % Mongoloid Buryats and 65 % Russians). Two hundred M. tuberculosis strains from newly-diagnosed patients were subjected to phenotypic testing and genotyping.

View Article and Find Full Text PDF

This study aimed to determine phenotypic and genotypic drug resistance patterns of strains from children with tuberculosis (TB) in China and Russia, two high-burden countries for multi/extensively-drug resistant (MDR/XDR) TB. Whole-genome sequencing data of isolates from China ( = 137) and Russia ( = 60) were analyzed for phylogenetic markers and drug-resistance mutations, followed by comparison with phenotypic susceptibility data. The Beijing genotype was detected in 126 Chinese and 50 Russian isolates.

View Article and Find Full Text PDF
Article Synopsis
  • * Among the Beijing strains, 50% are multidrug-resistant (MDR), with the B0/W148 group showing a significantly higher MDR prevalence (85.7%) compared to the Central Asian/Russian group (40.3%).
  • * The study identified various specific profiles within the Beijing strains, highlighting the need for focus on MDR variants due to their role in the increasing rates of MDR-TB transmission.
View Article and Find Full Text PDF